Goldman Sachs Group INC (GS) Stake Has Lifted by Ingalls & Snyder Llc

It's been a crucial week for The Goldman Sachs Group Inc.; here's what analysts have to say

It's been a crucial week for The Goldman Sachs Group Inc.; here's what analysts have to say

To adjust for differences in capital structure we'll use EBITDA margin and Return on Investment (ROI) as measures of profitability and return., compared to an EBITDA margin of 67.64% for The Goldman Sachs Group, Inc. The Sit Investment Associates Inc holds 24,933 shares with $5.91M value, down from 71,338 last quarter. The stock decreased 0.20% or $0.5 during the last trading session, reaching $253.83. Tirschwell & Loewy Inc bought 5,187 shares as the company's stock declined 1.69% while stock markets rallied. Credit Suisse Group cut shares of Goldman Sachs Group from an outperform rating to a neutral rating and raised their price target for the stock from $240.00 to $255.00 in a research note on Monday, October 9th. (The) (NYSE:GS) last posted its quarterly earnings results on Wednesday, January 18th. It has outperformed by 22.53% the S&P500.

More notable recent The Goldman Sachs Group, Inc. The Manufacturers Life Insurance Company now owns 3,602,847 shares of the investment management company's stock worth $799,472,000 after acquiring an additional 1,152,869 shares in the last quarter. The investment management company reported $5.02 EPS for the quarter, beating the consensus estimate of $4.17 by $0.85. About 738,538 shares traded. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has risen 2.17% since January 12, 2017 and is uptrending. It has outperformed by 41.94% the S&P500. The shares were sold at an average price of $245.18, for a total transaction of $1,812,615.74. It also upped Johnson & Johnson (NYSE:JNJ) stake by 8,070 shares and now owns 151,117 shares.

Investors sentiment decreased to 0.75 in 2017 Q3. The company has a market cap of $96,950.00, a P/E ratio of 13.35, a price-to-earnings-growth ratio of 0.93 and a beta of 1.47. It turned negative, as 63 investors sold GS shares while 427 reduced holdings. On Friday, October 20 the insider SCHWARTZ HARVEY M sold $6.13M. (NYSE:GS). Markston Ltd Liability holds 0.92% or 37,634 shares in its portfolio. The company has a debt-to-equity ratio of 2.82, a quick ratio of 0.90 and a current ratio of 0.90. (NYSE:GS). Arcadia Mi holds 0.04% or 500 shares. (NYSE:GS). Clear Harbor Asset Limited Liability Company accumulated 1,044 shares. Sandler O'Neill upgraded the shares of GS in report on Monday, October 12 to "Buy" rating. Qvt Financial Limited Partnership has invested 0.56% of its portfolio in The Goldman Sachs Group, Inc. (The) (NYSE:GS) by 3.0% during the third quarter, according to its most recent Form 13F filing with the SEC. Signaturefd Limited Liability, Georgia-based fund reported 2,922 shares. Of those holders, 448 had increased positions amounting to 11.98 million shares, 584 had decreased positions amounting to 19.19 million shares, and 226 holders have a held position accounting for 246.59 million shares. Old Second Bancorp Of Aurora invested in 0.01% or 151 shares. 5,375 are held by Canandaigua Bank Tru Com. 40,863 were accumulated by Main Street Ltd Liability Corporation.

Among 30 analysts covering Goldman Sachs Group Inc. Therefore 33% are positive. D E Shaw & invested 0.32% in The Goldman Sachs Group, Inc. The company was maintained on Tuesday, September 26 by Keefe Bruyette & Woods. GS is trading at, with an average price target of $271.15.

Analysts await The Goldman Sachs Group, Inc. Stockholders of record on Thursday, November 30th were given a dividend of $0.75 per share. The rating was downgraded by Citigroup to "Neutral" on Tuesday, November 8. (NASDAQ:AMZN) on Friday, August 25 with "Buy" rating. UBS maintained the stock with "Buy" rating in Friday, January 6 report. (NYSE:GS) earned "Hold" rating by BMO Capital Markets on Tuesday, July 18. (The) from $180.00 to $195.00 and gave the stock a "buy" rating in a research report on Monday, October 10th. The rating was maintained by Peel Hunt on Thursday, May 12 with "Hold".

Since August 1, 2017, it had 0 insider buys, and 6 selling transactions for $15.08 million activity. SOLOMON DAVID M also sold $754,997 worth of The Goldman Sachs Group, Inc. ROGERS JOHN F.W. sold $4.16M worth of stock or 17,685 shares. In the last ninety days, insiders have sold 135,177 shares of company stock valued at $32,435,160. The institutional investor held 3,602 shares of the finance company at the end of 2017Q3, valued at $854,000, down from 9,902 at the end of the previous reported quarter. JP Morgan upgraded the shares of GS in report on Tuesday, February 16 to "Overweight" rating. During the same period in the prior year, the business earned $4.68 earnings per share. Ltd. now owns 91,950 shares of the investment management company's stock valued at $21,810,000 after purchasing an additional 7,736 shares during the period. Volitionrx Ltd (NYSEMKT:VNRX) was raised too. Buckingham Research reissued a "neutral" rating and issued a $250.00 price objective (up previously from $243.00) on shares of Goldman Sachs Group in a research note on Wednesday, October 18th. Therefore 64% are positive. The stock of, Inc. The stock has "Buy" rating by Jefferies on Thursday, August 24. As per Friday, August 5, the company rating was maintained by Davy Research.

The Goldman Sachs Group, Inc. operates as an investment banking, securities, and investment management firm worldwide. As per Friday, February 5, the company rating was upgraded by Raymond James.

Among 3 analysts covering Ra Pharmaceuticals (NASDAQ:RARX), 3 have Buy rating, 0 Sell and 0 Hold. (NYSE:GS) to report earnings on January, 17 before the open. They expect $0.79 EPS, up 11.27% or $0.08 from last year's $0.71 per share. BAC's profit will be $4.80 billion for 16.59 P/E if the $0.46 EPS becomes a reality.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.